2024 annual financial data
Fennec Pharmaceuticals 2024 Operating margin
Fennec Pharmaceuticals 2024 operating margin with verified reported values.
Direct answer
Operating margin was 5.21%.
Operating income was 2,479,000 USD and net income was -436,000 USD.
Operating cash flow was 26,980,000 USD.
Get free Fennec Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 47,538,000 USD
- Operating income
- 2,479,000 USD
- Net income
- -436,000 USD
- Operating cash flow
- 26,980,000 USD